A High Resolution Autopsy Study Evaluating the Relationship of 18F-AV-1451 PET Imaging and Tau Pathology
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 16 Oct 2017
At a glance
- Drugs Flortaucipir F 18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- Sponsors Avid Radiopharmaceuticals
- 11 Oct 2017 Status changed from recruiting to active, no longer recruiting.
- 14 Sep 2017 Planned End Date changed from 1 Jun 2017 to 1 Oct 2017.
- 14 Sep 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Oct 2017.